Mobile App

Google Play Apple Store
Essentials in HCV: Best Practices Before and After the Cure - Updated 12/5/19
Certified CME/CNE/CPE Activity - Lecture Library Slide Set
The Simply Speaking Hepatitis lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Chronic HCV infection affects over 3 million Americans and is a leading cause of liver failure, cirrhosis, and liver cancer. There are an increasing number of young patients and patients with milder disease than described in previous years. Understanding nuances of HCV disease in different patient populations require clinicians to become continually educated on the safe and appropriate use of direct-acting antiviral agents in clinical practice. These slides use a case-based format to discuss the contemporary management of HCV infection before and after the cure in treatment-naïve and experienced patients with various comorbidities.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.
Review the slides by selecting the View Slide Kit button on the right. Claim 1 AMA, ANCC, or ACPE credit/contact hour per slide kit after completion of a brief posttest/evaluation.
Nancy Reau
Nancy Reau, MD, FAASLD, AGAF
Chief, Section of Hepatology
Richard B. Capps Chair of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center





20

Supported by an independent educational grant from Gilead Sciences Medical Affairs

April 30, 2020
Mini Module
6340
SSLectureLibrary_WebBanner_HEP1150.gif
Liver Disease